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Abstract Using expressed sequence tag data, we obtained a
full-length cDNA encoding a wheat protein inhibitor of xylanases
(XIP-I). The 822 bp open reading frame encoded a protein of 274
amino acids with a molecular mass of 30.2 kDa, in excellent
agreement with the native protein. Expression in Escherichia coli
confirmed that the cDNA encoded a functional endo-1,4-L-D-
xylanase inhibitor. Its deduced amino acid sequence exhibited
highest similarity to sequences classified as class III chitinases,
but the inhibitor did not exhibit chitinase activity. This is
the first full-length cDNA sequence that encodes a novel
class of protein which inhibits the activity of endo-1,4-L-D-
xylanases. . 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
Key words: Xylanase; Protein inhibitor; Wheat; Expressed
sequence tag; Heterologous expression; Triticum aestivum
1. Introduction
A novel class of protein inhibitors has recently been discov-
ered that inhibited fungal but not bacterial xylanases (endo-
1,4-L-D-xylanase, EC 3.2.1.8) [1,2]. This inhibitor protein,
named XIP-I, was puri¢ed from wheat £our (Triticum aesti-
vum var. Soisson) and partially characterised [1]. It is a mono-
meric, glycosylated protein with a pI of 8.7^8.9 and a molec-
ular mass of 29.0 kDa. It inhibited reversibly, and in a
competitive manner, family 11 xylanases [3] from Aspergillus
niger and Trichoderma viride [1,2]. A second protein named
Triticum aestivum xylanase inhibitor (TAXI) that exhibited
inhibitory activity towards fungal and bacterial xylanases
has also been isolated from wheat £our [4]. It was subse-
quently shown that two forms of TAXI were present in wheat
(denoted TAXI-I and TAXI-II) [5]. TAXI-I and TAXI-II
have molecular masses of approx. 40.0 kDa, are not glycosy-
lated and occur in two molecular forms, i.e. a non-proteolyti-
cally processed one and a proteolytically processed one. How-
ever, TAXI-I and TAXI-II were distinguished by di¡erent
inhibition activities towards various xylanases and di¡erent
pI values (8.8 and V9.3 respectively) [4]. The N-terminal
amino acid sequences of TAXI-I and TAXI-II showed a
high degree of identity, but there was no similarity to XIP-I.
The physiological function of these inhibitors is still un-
known but it has been suggested that they play a role in plant
defence [1,5]. In addition these inhibitors are of particular
importance to industrial applications such as baking [4],
wheat processing [6] brewing [7], or animal feed [8] where
they hamper the e⁄cacy of xylanases, which are added during
the manufacturing process.
In this paper we identify the ¢rst full-length cDNA se-
quence encoding a xylanase inhibitor from wheat. We show
that this sequence encodes a soluble and active recombinant
protein when expressed heterologously in Escherichia coli.
2. Materials and methods
2.1. Strains and plasmids
E. coli DH5K (supE44, hsdR17, recA1, endA1, gyrA96, thi-1, relA1)
was from Stratagene and BL21 (DE3) (F3, ompT, hsdSB, (r3B , m
3
B ),
dcm, gal, VDE3) from Novagen. The E. coli vector pGEM-Teasy was
from Promega, pBluescript KS from Stratagene, and pET24a from
Novagen. Both expressed sequence tags (ESTs) were cloned in the
Lambda Uni-ZAP XR vector (Stratagene), provided by Dr. Olin An-
derson (U.S. Department of Agriculture, Albany, USA) and excised
to give pBluescript phagemids.
2.2. Peptide sequencing of native XIP-I
N-terminal amino acid sequencing was performed using automated
Edman degradation at the John Innes Centre, UK. For internal se-
quencing, native XIP-I was ¢rst digested with trypsin [1].
2.3. Polymerase chain reaction (PCR)
Oligonucleotides were purchased from Sigma-Genosys. Nested-
PCR using degenerate primers, based on the peptidic sequence data,
was used to produce a nucleotide fragment corresponding to part of
the sequence encoding XIP-I. First round ampli¢cation reactions were
performed using the primers 5P-GBAACACBGGBCARGTSAC-3P
(Fn5) and 5P-ACVGTBGCVGTNAGRTG-3P (Rii5); second round
reactions were performed using the primers 5P-GBCARGT-
SACBGTSTTCTG-3P (Fn3) and 5P-TGNAGSGGGTTVCCSGG-3P
(Rii3). Reaction mixtures (50 Wl) for both ¢rst and second round
reactions were in 10 mM Tris^HCl bu¡er, pH 9.0 containing 50
mM KCl, 1.5 mM MgCl2, 0.1% (v/v) Triton X-100, 5 WM tetrame-
thylammonium chloride (Sigma), 0.2 mM each of dATP, dTTP,
dGTP and dCTP and 5 U Taq DNA polymerase (Promega). Ampli-
¢cations were carried out on a Model 2400 thermal cycler (Perkin
Elmer). First round reactions contained 25 pmol Fn5 and Rii5 and
genomic DNA (250 ng) puri¢ed from shoots of 7 day old T. aestivum
var. Soisson wheat using the DNEasy Plant Mini kit (Qiagen). PCR
conditions were: 94‡C for 2 min; 94‡C for 1 min, 50‡C for 1 min,
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72‡C for 3 min (30 cycles); 72‡C for 10 min. Second round reactions
contained 25 pmol of Fn3 and Rii3 and an aliquot (2 Wl) of the ¢rst
round reaction as template. PCR conditions were: 95‡C for 5 min;
95‡C for 1 min, 52‡C for 1 min, 72‡C for 2 min (30 cycles); 72‡C for
7 min. A 450 bp product (called XI47) was obtained, puri¢ed using a
QIAquick gel extraction kit (Qiagen), subcloned into the pGEM-T
Easy vector, and subjected to DNA sequencing.
The overlap extension PCR was performed to amplify the complete
open reading frame (ORF) encoding XIP-I [9]. The 5P-end of XIP-I
from the EST WHE1701-1704_I04_I04ZS (kindly donated by Dr Olin
Anderson) was ampli¢ed by PCR with the primers 5P-AC-
CTGTCACTCATATGGGCGGGGGGAAAGAC-3P (named NdeI
5P) and 5P-AGGGGCGGGGGACGCTCGGCTTG-3P (named NdeI
3P). Reaction mixtures (100 Wl) were in 20 mM Tris^HCl bu¡er, pH
8.8, containing 1.5 mM MgCl2, 110 mM KCl, 10 mM (NH4)2SO4,
0.1% (v/v) Triton X-100, 0.1 mM each of dATP, dTTP, dGTP and
dCTP, 1 mg/ml nuclease free BSA, 2.5 U Pfu DNA polymerase (Stra-
tagene), 0.4 Wg plasmid and 500 pmol of each primer. PCR conditions
were: 94‡C for 5 min; 94‡C for 1 min, 42‡C for 2 min, 72‡C for 3 min
(30 cycles); 72‡C for 7 min. A PCR product of the expected size (360
bp) was obtained. The 3P-end of XIP-I from the EST WHE1205_-
C08_E15ZS (kindly donated by Dr Olin Anderson) was ampli¢ed by
PCR with the primers 5P-ACTCCTACTTCGGCGGGTCCAAGCC-
GAG-3P (named BamHI 5P) and 5P-TCACTGTCCAGGATCCT-
TAGGCGTAGTAGTACTTGATC-3P (named BamHI 3P). The
PCR conditions were as described above to yield a 540 bp product.
Both PCR products, obtained from the ¢rst round of reactions, were
gel-puri¢ed and subjected to a second round of PCR. Reaction mix-
tures (100 Wl) were in 20 mM Tris^HCl bu¡er, pH 8.8, containing 10
mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% (v/v) Triton X-
100, 0.1 mM each of dATP, dTTP, dGTP and dCTP, 2 U Vent DNA
polymerase (New England Biolabs), and 0.4 Wg of each of the ¢rst
round PCR products. PCR conditions were: 94‡C for 1 min, 42‡C for
2 min, 72‡C for 3 min (¢ve cycles), after which 500 pmol of the
primers NdeI 5P and BamHI 3P were added, and a further 25 cycles
(under the same PCR conditions) were used to generate an 850 bp
product. The PCR product was digested with NdeI/BamHI, gel-puri-
¢ed, and cloned into pET24a. The ¢nal construct was referred to as
pETXIP-I and transformed into BL21(DE3) for protein expression
and sequencing.
2.4. Sequence analysis
DNA sequencing was carried out with an Applied Biosystems Mod-
el 373A automated DNA sequencer using dye termination chemistry
at the University of Durham. Homology searches for nucleotide se-
quences against the EST database dbEST [10] were performed using
BLAST [11] at the National Centre for Biotechnology Information
(NCBI). Homology searches for protein sequences against the swall
database was carried out using FASTA3 [12] at the European Bio-
informatics Institute. Sequence data was analysed using the Genetics
Computer Group Wisconsin Package version 10 (Accelrys).
2.5. Heterologous expression of XIP-I in E. coli
Luria^Bertani (LB) medium (50 ml) was inoculated with an over-
night culture (0.5 ml) derived from a single colony of BL21(DE3)
[pETXIP-I] or BL21(DE3)[pET24a]. The cultures were grown at 37‡C
(200 rpm) until A600nm 1.0 and then transferred to 25‡C. After addi-
tion of isopropyl-thio-L-D-galactopyranoside (Sigma; 1 mM ¢nal con-
centration) and incubation for 18 h at 200 rpm, cells were harvested
by centrifugation (3000Ug, 15 min, 4‡C), resuspended in McIlvaine’s
bu¡er (0.1 M citric acid/0.2 M Na2HPO4, pH 5.5), sonicated (4U15 s
on ice), and centrifuged (13 000Ug, 15 min, 4‡C). The soluble protein
extracts (0.5 ml) were desalted on Sephadex G-25 columns (NAP-5;
Amersham Pharmacia Biotech.) and tested for xylanase inhibitor ac-
tivity.
2.6. Activity assays
Xylanase activity was determined using the 3,5-dinitrosalicylic acid
(Sigma) method [13] with 1% w/v birchwood (1,4)-L-xylan (Fluka) at
30‡C in McIlvaine’s bu¡er. One unit of xylanase activity was de¢ned
as the amount of protein that released 1 Wmol xylose per min at 30‡C
and pH 5.5.
Xylanase inhibitor activity was determined by measuring the activ-
ity of a family 11 xylanase from Aspergillus awamori var. awamori [14]
in the presence and absence of XIP-I [1]. Reactions (in triplicate)
containing Aspergillus xylanase (6 Wl, 277 ng) alone, or pre-incubated
(5 min, 30‡C) with soluble protein extracts (94 Wl) from transformed
E. coli, were assayed for xylanase activity. One unit of xylanase in-
hibitor activity was de¢ned as the amount of protein that caused a
reduction in absorbance at 550 nm of 0.1 absorbance units at 30‡C
and pH 5.5.
Recombinant XIP-I (reXIP-I) was assayed for chitinase activity by
measuring the release of Remazol Brilliant Violet 5R from dyed chitin
at 35‡C in McIlvaine’s bu¡er [1,15].
2.7. Gel electrophoresis and immunoblotting
SDS^PAGE gel electrophoresis was carried out on 10% bis^Tris
pre-cast NuPAGE gels (Invitrogen) with biotinylated marker proteins
(New England Biolabs). Proteins were transferred to nitrocellulose
membranes by semi-dry blotting (Bio-Rad) [16]. The blots were
probed with a 5000-fold dilution of polyclonal antiserum raised in
rabbits against XIP-I puri¢ed from wheat. Immunoreactive proteins
were visualised using a horseradish peroxidase anti-rabbit secondary
antibody (Sigma; 1:2000) together with the chemiluminescent detec-
tion reagents (ECL Plus Detection Kit, Amersham Pharmacia Bio-
tech.). Isoelectric focusing gels were run using the Phast system
(Amersham Pharmacia Biotech.).
2.8. Puri¢cation of native and reXIP-I
XIP-I was puri¢ed from wheat (T. aestivum var. Soisson) £our as
previously described [1]. ReXIP-I was puri¢ed from an induced cul-
ture (500 ml) of BL21(DE3)[pETXIP-I]. Crude soluble protein extract
in McIlvaine’s bu¡er (10 ml) was exchanged into 20 mM Tris^HCl,
pH 7.0 bu¡er on PD-10 columns (Amersham Pharmacia Biotech.) and
loaded onto a Mono-Q HR 10/10 column equilibrated in the same
bu¡er using an Aº KTA fast protein liquid chromatography system
(Amersham Pharmacia Biotech.). Proteins were eluted at 1 ml/min
with a linear gradient of 0^1 M NaCl in the same bu¡er. Fractions
containing inhibitory activity were pooled (8 ml), dialysed extensively
against McIlvaine’s bu¡er, and concentrated to 0.5 ml using a Cen-
tricon-3 (Millipore). The sample was applied to a Superdex 75 10/30
column equilibrated in the same bu¡er, eluted at 0.5 ml/min, and
fractions (1 ml) were assayed for inhibitory activity and analysed by
Western blotting.
3. Results and discussion
3.1. Cloning of XIP-I full-length cDNA and sequence analysis
The overall strategy for obtaining a full-length cDNA cor-
responding to T. aestivum var. Soisson XIP-I involved (1)
generation of a partial xip-I cDNA using PCR with degener-
ate primers (designed from peptide sequences obtained with
highly puri¢ed XIP-I) and genomic DNA, (2) generation of a
consensus sequence by alignment of EST sequences that were
highly similar to the partial xip-I, and (3) PCR cloning of full-
length xip-I from two overlapping ESTs that showed 100%
identity with the partial xip-I cDNA and peptide sequences
for native XIP-I.
We have previously reported the N-terminal sequence of the
¢rst 15 amino acids of native XIP-I puri¢ed from T. aestivum
var. Soisson. From the puri¢ed protein we have now se-
quenced the ¢rst 50 amino acids (AGGKTGQVTVFWG-
RNKAEGSLREACDSGMYTMVTMSFLDVFGAN(C/G)-
KYHLD) as well as three internal peptides (1. NVYYGVAP-
VAQK, 2. GGPGKPLHLTATVR, 3. FYVGLTADDKSHQ-
WVHPK). A 450 bp putative xip-I PCR product (XI47) was
obtained using degenerate primers based on the N-terminal
and internal amino acid sequences of the puri¢ed XIP-I.
The XI47 DNA sequence was used as a probe to screen the
EST databases at the NCBI. A total of 19 ESTs were ob-
tained, which when aligned, produced a consensus sequence
which showed high similarity with the deduced amino acid
sequence of the XI47 cDNA fragment (Fig. 1). The N-ter-
minal peptide and three internal peptides could be aligned
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with the translated ORF of the consensus sequence with an
overall identity of 99% over 94 amino acids (Fig. 1). Therefore
this sequence was a very good candidate to represent the
cDNA clone encoding XIP-I. This consensus sequence dif-
fered from the peptide data derived from native XIP-I by
one amino acid (L37F). The complete nucleotide sequence
of this cDNA consisted of 955 bp. It contained an ORF of
822 bp encoding a protein of 274 amino acids (Fig. 1). The
predicted signal peptide was 30 amino acids long, in good
agreement with the N-terminal sequence of the mature protein
[1]. The calculated molecular mass of 30 222 Da was in ex-
cellent agreement with that of 30 657 Da obtained by matrix-
assisted laser desorption time-of-£ight mass spectrometry on
puri¢ed XIP-I (Flatman et al., unpublished results). Native
XIP-I has been reported to be weakly glycosylated [1], and
the slight di¡erence in molecular mass could be accounted to
three sugar residues.
Analysis of the ESTs used in the construction of the con-
sensus sequence identi¢ed two sequences (WHE1701-
1704_I04_I04ZS, accession BE605137 and WHE1205_-
C08_E15ZS, accession BE404812) that covered the entire con-
sensus sequence and which overlapped by 30 bp (nt 392^434,
Fig. 1). The 436 bp sequence of WHE1701-1704_I04_I04ZS
was detected in a cDNA library from the whole spikes of heat
Fig. 1. Nucleotide and amino acid sequence of XIP-I, and alignment with XIP-I peptides. XIP-I peptides are underlined, identical residues are
shaded, the signal peptide is indicated by a dashed line and the stop codon is denoted by an asterisk. The sequence in bold corresponds to the
overlapping nt region of the two wheat ESTs (accession numbers: BE605137 and BE404812).
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stressed wheat (T. aestivum var. Chinese Spring) at 5, 10, 15
and 20 days after anthesis. The 562 bp sequence of
WHE1205_C08_E15ZS was detected in a cDNA library
from the roots of 5 day old aetiolated seedlings (T. aestivum
var. Chinese Spring). Fusion of these two wheat EST sequen-
ces by PCR led to a full-length cDNA encoding XIP-I (EMBL
accession number AJ422119). The signal sequence was not
incorporated into the ¢nal product and the TGA stop codon
was changed to TAA for protein expression purposes since the
former can be mistranslated to tryptophan when expressed in
E. coli [17]. Direct sequencing of the EST fusion cDNA (xip-I)
revealed that the amino acid change (L37F) observed in the
consensus sequence is not present in the actual cDNA, and
that this change was in fact a sequencing error reported in the
EST WHE1701-1704_I04_I04ZS. This also con¢rms that the
cDNA is 100% identical to the peptide sequences derived from
native XIP-I (Fig. 1).
3.2. Sequence alignment and structural homology
XIP-I showed overall homology with a number of class III
chitinases (family 18 glycosidases [3]) from rice, pokeweed,
apple, strawberry, grape, tobacco, maize, cowpea, the rubber
plant (Hevea brasiliensis), and concanavalin B (a lectin from
jackbean) [3] (Fig. 2). Among these sequences, only H. brasi-
liensis chitinase cDNA is known to encode a protein (hev-
amine A) exhibiting chitinase activity [18]. XIP-I shared 63,
47, and 42% similarity and 55, 36, and 33% identity with the
rice class III chitinase [19], hevamine A [20], and concanavalin
B [21] sequences, respectively.
Molecular modelling of XIP-I based on the known crystal
structures of hevamine A [22] and concanavalin B [23],
showed that all three proteins presented a typical ‘TIM-barrel’
[24] (L/K)8-fold (data not shown).
3.3. Functional expression in E. coli
Conclusive demonstration that the ORF included in the
consensus sequence encoded XIP-I was obtained by heterolo-
gous expression in E. coli. Full-length xip-I cDNA was cloned
into pET24a to give the expression construct pETXIP-I. The
expressed protein lacked the signal peptide and was a non-
fusion protein with no additional amino acids at the N- and
C-termini. The soluble protein fraction obtained from a cul-
ture of E. coli transformed with pETXIP-I contained an im-
munoreactive polypeptide of Mr 29 kDa that co-migrated on
SDS^PAGE gels with native XIP-I (Fig. 3) and also contained
Fig. 2. Multiple sequence alignments of XIP-I and related proteins. The EMBL accession numbers of rice class III chitinase, hevamine A, and
concanavalin B are 049828, AJ007701, and X83426, respectively. Residues which are identical in all sequences are shaded.
Fig. 3. Gel electrophoresis of reXIP-I. A: Western blot analysis of
(lane 1) crude soluble protein extracts of E. coli BL21(DE3)[pET-
XIP-I], (lane 2) crude soluble protein extracts of E. coli
BL21(DE3)[pET24a], (lane 3) native XIP-I (20 ng) (lane 4) reXIP-I
after puri¢cation by gel-¢ltration, (lane 5) native XIP-I (20 ng). B:
Isoelectric focusing of (lane 1) pI markers (from lentil lectin; Sigma)
(lane 2) partially puri¢ed reXIP-I, (lane 3) native XIP-I (25 ng).
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xylanase inhibitor activity (Fig. 4). No similar protein or ac-
tivity could be detected from the corresponding fraction from
a culture transformed with pET24a. The speci¢c inhibitor
activity of reXIP-I in the crude extract was 19 200 U/mg,
very similar to that of 11 700X 1600 U/mg obtained with the
native enzyme under the same conditions. This indicated that
soluble, active, reXIP-I was expressed in E. coli. Isoelectric
focusing showed that reXIP-I had an apparent pI value of
9.0, which was in excellent accordance with that of the native
protein (Fig. 3). Two isoforms of pI 8.7 and 8.9 were detected
for native XIP-I; the lower value was due to modi¢cations
upon storage or during the puri¢cation process (Flatman et
al., unpublished results).
Analysis of reXIP-I in crude soluble protein extracts and
after puri¢cation by gel-¢ltration, showed that the protein
rapidly lost its biological activity, in contrast to native XIP-
I, which was stable under the same conditions (no loss of
inhibitor activity was detected after 48 h at 4‡C). The loss
in biological activity of reXIP-I could not be attributed to
proteolysis of the protein during expression and/or puri¢ca-
tion since no lower Mr immunoreactive polypeptides were
detected on immunoblots (Fig. 3). Moreover, reXIP-I ex-
pressed at 37‡C for a shorter period of time (3 h) was also
soluble, but its activity was similarly unstable (Fig. 4). The
solubility of reXIP-I also suggested that the incorrect forma-
tion of disulphide bonds in the protein when expressed in the
E. coli cytoplasm was not a reason for the instability. More-
over, the protein behaved similarly on gels in reducing and
non-reducing conditions, as described for native XIP-I [1].
The presence of some degree of glycosylation (approx. 2%
w/w) on native XIP-I was previously reported [1] and, taken
together, the data suggest that glycosylation is involved in
stabilising the activity of native XIP-I.
As previously found for native XIP-I [1], we could not
detect any chitinase activity towards the insoluble substrate
chitin azure for reXIP-I. These results suggest that XIP-I is a
novel class of protein that may have evolved to inhibit xylan-
ases rather than to function as a chitinase. This is particularly
relevant to its physiological role in the wheat plant since the
activity of plant chitinases are regulated in response to fungal
elicitors [25], and they exhibit rapid evolution by acting as
prime targets for the co-evolution of plant^pathogen interac-
tions [26].
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Fig. 4. Xylanase inhibitor activity of reXIP-I. Crude soluble protein
extracts were prepared from the soluble fraction of E. coli
BL21(DE3)[pET24a] and BL21(DE3)[pETXIP-I] cultures grown at
25‡C for 18 h, or at 37‡C for 3 h (see Section 2) and assayed for
xylanase inhibitor activity using birchwood (1,4)-L-xylan as substrate
and A. awamori xylanase as the target enzyme. The residual xylan-
ase activity is shown for each fraction.
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